Sign in
CRGX Stock Price, Chart, Stats & News
CARGO Therapeutics, Inc. Common Stock
Save
CARGO Therapeutics, Inc. Common Stock (CRGX) does not currently pay a dividend.
216.19M
Market cap
–
Current P/E
–
Forward P/E
CRGX chart
Price history is unavailable
We don't have enough price data for CRGX to draw a chart yet.
Fundamentals
Gross margin | -62.94% |
Operating margin | -3046.87% |
Pretax margin | -2832.41% |
Net margin | -2832.41% |
Effective tax rate | – |
ROA | -85.76% |
ROE | -69.24% |
D/E | 0.00x |
Interest coverage ratio | – |
CRGX valuation
P/E | – |
P/S | 27.61x |
P/B | 0.91x |
P/CF | -1.13x |
P/FCF | -1.12x |
P/OCF | -1.13x |
PEG | 2.26x |
EV multiple | -2.30x |
About
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions.
Similar securities
Based on sector and market capitalization
Report issue